If you are on a GLP-1 medication , working with a healthcare provider to monitor body composition and nutritional intake can help optimize results and preserve muscle mass
Tang NL, Ganapathy V, Wu X, Hui J, Seth P, Yuen PM, Wanders RJ, Fok TF, Hjelm NM: Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency
However, their efficacy has limitations, particularly in patients with morbid obesity, where they may not produce enough weight loss to control or resolve the disease fully
PMID: 35949559
While weight loss is known to curb cancer risks, GLP-1s may act on other brain and metabolic pathways to prevent cancer
The risk of biliary disease is real, but again, folks who have sluggish gallbladders tend to be on that heavier set type 2 diabetic group